Temozolomide [temozolomid]
- Terms
-
Temodal
Temozolomid
-
8-Carbamoyl-3-methylimidazo(5,1-d)-1,2,3,5-tetrazin-4(3H)-one
CCRG 81045
CCRG-81045
M&B 39831
M&B-39831
Methazolastone
NSC 362856
NSC-362856
Temodal
Temodar
Temozolomide Hexyl Ester
TMZ-Bioshuttle
TMZA-HE
A dacarbazine derivative that is used as an alkylating antineoplastic agent for the treatment of MALIGNANT GLIOMA and MALIGNANT MELANOMA.
- DUI
- D000077204 MeSH Browser
- CUI
- M0136562
- History note
- 2019 (1985)
- Public note
- 2019; TEMOZOLOMIDE was indexed under DACARBAZINE 1989-2019, and under IMIDAZOLES 1985-1988
Allowable subheadings
- AD
- administration & dosage 6
- AE
- adverse effects 1
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics 1
- PD
- pharmacology 4
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 8
- TO
- toxicity
- UR
- urine